G1389R (p.Gly1389Arg) variant of VPS13C (Q709C8)
G1389R (p.Gly1389Arg) in VPS13C (Q709C8) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Young-onset Parkinson disease; not provided; Parkinson disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data, published literature, and structural context.
G1389R (p.Gly1389Arg) variant details
- p.Gly1389Arg
- rs369100678
- ClinGen CA351343
- ClinVar RCV000210217
- ClinVar RCV000236463
- Pathogenic/Likely pathogenic
- Young-onset Parkinson disease; not provided; Parkinson disease
- Missense
- Variant Prioritization Score for Impact Estimate 0.294
- REVEL 0.05
- ESM-1b 0.00
- AlphaMissense 0.09
- MetaLR 0.06
- MetaSVM -1.14
- CADD 35.00
- ClinVar: Pathogenic/Likely pathogenic (Young-onset Parkinson disease; not provided; Parkinson disease)
- EBI: Pathogenic (in PARK23)
- UniProt: Pathogenic (in PARK23)
- Most common in the Non-Finnish European population (allele frequency 3.1e-05)
- Structural context available
- Cited in: Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases… (PMID 26942284)
- Cited in: Monogenic Parkinson Disease Overview. (PMID 20301402)